Open-label crossover trial for the efficacy and safety of switching to HIF-PH inhibitor in anemic patients with maintenance hemodialysis treated by ESA.
Not Applicable
- Conditions
- hemodialysis patient
- Registration Number
- JPRN-UMIN000042873
- Lead Sponsor
- akajima tsuchiya clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients who have difficulty in taking oral medicine. 2.Patients on concomitant peritoneal dialysis. 3.Patients judged by the investigator to be unsuitable as subjects.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hb
- Secondary Outcome Measures
Name Time Method Fe,ferritin,TSAT